About nika pharmaceuticals inc - NIKA
Nika Pharmaceuticals, Inc. engages in the development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. Its products include veterinary medicinal products, plant protection products, other dietary supplements, and generic drugs. The company was founded on June 8, 2000 and is headquartered in Henderson, NV.
NIKA At a Glance
Nika Pharmaceuticals, Inc.
2269 Merrimack Valley Avenue
Henderson, Nevada 89044
| Phone | 1-702-326-3615 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Other | Net Income | -76,398.00 | |
| Sector | Health Technology | Employees | N/A | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
NIKA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -5,211.689 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
NIKA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
NIKA Liquidity
| Current Ratio | 0.066 |
| Quick Ratio | 0.066 |
| Cash Ratio | 0.006 |
NIKA Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -392.489 |
| Return on Equity | N/A |
| Return on Total Capital | 25.669 |
| Return on Invested Capital | N/A |
NIKA Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |